CLINICAL TRIALS PROFILE FOR BEPOTASTINE BESILATE
✉ Email this page to a colleague
All Clinical Trials for bepotastine besilate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00424398 ↗ | Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis | Completed | Bausch & Lomb Incorporated | Phase 2/Phase 3 | 2007-02-01 | The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis |
| NCT00586625 ↗ | Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers | Completed | Bausch & Lomb Incorporated | Phase 3 | 2007-10-01 | Safety study for bepotastine besilate ophthalmic solution in normal volunteers |
| NCT00586664 ↗ | Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis | Completed | Bausch & Lomb Incorporated | Phase 3 | 2007-10-01 | Efficacy and safety study of bepotastine besilate ophthalmic solution in allergic conjunctivitis |
| NCT01128556 ↗ | The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing | Completed | North Texas Institute for Clinical Trials | Phase 4 | 2010-04-01 | To evaluate the effect of BEPREVE compared to a REFRESH Tears Lubricant eye drop on the measurement of the wheal and flare from histamine skin prick testing. This is an open label, two-week, post-marketing study conducted on histamine responsive patients. |
| NCT01174823 ↗ | Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients | Completed | Bausch & Lomb Incorporated | Phase 2 | 2010-06-01 | The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients. |
| NCT01222299 ↗ | Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber | Completed | Bausch & Lomb Incorporated | Phase 1/Phase 2 | 2010-05-01 | The purpose of this study is to examine the safety and efficacy of bepotastine besilate nasal product in seasonal allergic rhinitis patients. |
| NCT01277341 ↗ | Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis | Completed | Bausch & Lomb Incorporated | Phase 2 | 2010-12-01 | This is an efficacy study of bepotastine besilate nasal spray in seasonal allergic rhinitis. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for bepotastine besilate
Condition Name
Clinical Trial Locations for bepotastine besilate
Trials by Country
Clinical Trial Progress for bepotastine besilate
Clinical Trial Phase
Clinical Trial Sponsors for bepotastine besilate
Sponsor Name
